Core Viewpoint - The private hospital sector has shown a positive performance with a 1.35% increase, ranking sixth among concept sectors, driven by significant gains in several stocks [1][2]. Group 1: Market Performance - As of November 14, the private hospital concept saw 42 stocks rise, with notable performers including Hainan Haiyao, Dazhongfang, and Renmin Tongtai, which hit the daily limit up [1]. - The top gainers in the sector included Hainan Haiyao with a 10.08% increase, Dazhongfang at 10.06%, and Xinlong Holdings at 9.99% [3]. - Conversely, the biggest losers were *ST Wanfang, Madi Technology, and Samsung Medical, which fell by 5.06%, 3.09%, and 2.76% respectively [1][2]. Group 2: Capital Flow - The private hospital sector experienced a net outflow of 382 million yuan in principal funds, with 28 stocks seeing net inflows and 10 stocks exceeding 10 million yuan in net inflows [2]. - Hainan Haiyao led the net inflow with 256 million yuan, followed by Dazhongfang, Xinlong Holdings, and Kaikai Industry with net inflows of 178 million yuan, 118 million yuan, and 106 million yuan respectively [2][3]. - The highest net inflow ratios were recorded by Xinlong Holdings at 48.07%, ST Zhongzhu at 42.18%, and Hainan Haiyao at 39.26% [3].

Core Insights - The private hospital sector saw a slight increase of 0.29%, ranking 9th among concept sectors, with 32 stocks rising, including Guizhou Bailing and Luoxin Pharmaceutical hitting the daily limit [1][2] Sector Performance - The top-performing concept sectors included Hainan Free Trade Zone (+2.58%) and Military Equipment Restructuring (+1.98%), while sectors like Special Steel (-2.68%) and Photolithography (-2.47%) faced declines [2] - The private hospital sector attracted a net inflow of 201 million yuan, with 29 stocks receiving inflows, and 6 stocks exceeding 50 million yuan in net inflow [2] Stock Highlights - Notable stocks in the private hospital sector included: - New Mileage: +9.87% with a net inflow of 161.24 million yuan and a net inflow ratio of 19.36% [3] - Guizhou Bailing: +9.98% with a net inflow of 95.37 million yuan and a net inflow ratio of 33.91% [3] - Luoxin Pharmaceutical: +9.94% with a net inflow of 77.86 million yuan and a net inflow ratio of 35.07% [3] - Other significant gainers included Hainan Haiyao (+6.14%) and Xinfeng Pharmaceutical (+3.20%) [1][3] Decliners - The stocks with the largest declines included: - Pingtan Development: -4.53% [1] - Xiangjiang Holdings: -3.06% [7] - Anke Biotechnology: -2.48% [7]